Kraig Biocraft Laboratories, a developer of spider silk-based fibers, announced that its previously announced research and production facility in Michigan is now operational. The new facility will enable the domestic production of the spider silk-based fibers, centralize the company’s research and development program for new polymers, and facilitate relocated production operations from Indiana.

VBL Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of cancer treatments, announced the opening of a new gene therapy manufacturing facility in Modiin, Israel. The site will facilitate the production of the company's lead cancer drug candidate, ofranergene obadenovec, if approved.

DCPrime BV, a clinical stage company focused on dendritic cell vaccines to treat cancer, and Apceth Biopharma GmbH, a contract manufacturing organization specializing in gene and cell therapy, announced their collaboration in the clinical batch production and the development of a commercial-scale manufacturing process of cancer vaccines.

Rutgers University-based C-SOPS annual meeting described advances in continuous manufacturing understanding and future plans for broader education efforts.At an industry meeting of the Center for Structured Particulate Systems (C-SOPS) held at Rutgers University on Oct.

The partnership and the formation of the institute intend to bring together industry, academia, and regulators to tackle challenges and provide solutions for continuous manufacturing.The New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation, and Rutgers University announced plans on Oct. 16

The partnership and the formation of the institute intend to bring together industry, academia, and regulators to tackle challenges and provide solutions for continuous manufacturing.The New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation, and Rutgers University announced plans on Oct. 16